Immuno-Oncology NewsExperts Discuss Role of Cancer Immunotherapy at Bristol-Myers Presentation, Panel DiscussionImmuno-Oncology NewsVicki Goodman, MD, head of New Asset Development at BMS, reminds us that immunotherapy can be used early in two settings… Continue reading
Immuno-Oncology NewsExperts Discuss Role of Cancer Immunotherapy at Bristol-Myers Presentation, Panel DiscussionImmuno-Oncology NewsVicki Goodman, MD, head of New Asset Development at BMS, reminds us that immunotherapy can be used early in two settings… Continue reading
Deccan HeraldPact for stem cell bank renewedDeccan HeraldThe DBT already has a partnership with the Kyoto University on the induced human stem cell research. Two Japanese researchers were brought into Indian research programmes involving National Centr… Continue reading
Deccan HeraldPact for stem cell bank renewedDeccan HeraldThe DBT already has a partnership with the Kyoto University on the induced human stem cell research. Two Japanese researchers were brought into Indian research programmes involving National Centr… Continue reading
Times Online – Auckland |
Stem cell treatment “best thing I ever did”
Times Online – Auckland Desperate to recover and improve her quality of life for her young family, she was busy fundraising for the only known treatment to stop Multiple Sclerosis (MS) in its tracks — Autologous Hematopoetic Stem Cell Transplantation (AHSCT). MS is a long … |
|
Kite-Gilead: Winners And Losers Part 2
Seeking Alpha This in essence “programs” the T-cell to recognize cancer cells that express an antigen on the cell surface that matches the new added antibody. When the CAR T cell finds the matching antigen, it binds to the cell and triggers an immune response to … |
|
Editas Medicine, Inc. (NASDAQ:EDIT) Sees Stock Price Rise – Up by 5.6834%
First News 24 CRISPR uses a protein-ribonucleic acid (RNA) complex composed of an enzyme, including either Cas9 (CRISPR associated protein 9) or Cpf1 (CRISPR from Prevotella and Francisella 1), bound to a guide RNA molecule designed to recognize a particular … |
R & D Magazine |
Breakthrough Could Lead to Better Stem Cell Production
R & D Magazine A research team has unlocked a potential alternative approach to manufacturing induced pluripotent stem cells (IPSCs). Scientists at The Scripps Research Institute (TSRI) found a way to harness antibodies that were able to help “reprogram” ordinary … |